Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Taxes (2016 - 2021)

Altimmune (ALT) has disclosed Change in Taxes for 6 consecutive years, with $2.6 million as the latest value for Q3 2021.

  • On a quarterly basis, Change in Taxes rose 276.83% to $2.6 million in Q3 2021 year-over-year; TTM through Sep 2025 was $1.7 million, a N/A change, with the full-year FY2020 number at $7.1 million, up 1977.9% from a year prior.
  • Change in Taxes was $2.6 million for Q3 2021 at Altimmune, up from -$1.0 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $3.4 million in Q1 2020 to a low of -$2.9 million in Q2 2018.
  • A 5-year average of $357730.5 and a median of $203008.0 in 2017 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: crashed 662.91% in 2018, then surged 10982.67% in 2020.
  • Altimmune's Change in Taxes stood at $1.3 million in 2017, then crashed by 118.79% to -$237442.0 in 2018, then crashed by 42.98% to -$339501.0 in 2019, then soared by 562.13% to $1.6 million in 2020, then soared by 64.98% to $2.6 million in 2021.
  • Per Business Quant, the three most recent readings for ALT's Change in Taxes are $2.6 million (Q3 2021), -$1.0 million (Q2 2021), and $135274.0 (Q1 2021).